Silence Therapeutics (SLN) Institutional Ownership → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free SLN Stock Alerts $23.00 +0.06 (+0.26%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Silence Therapeutics (NASDAQ:SLN)CurrentInstitutional OwnershipPercentage98.73%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$91.53MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$6.54M Get SLN Insider Trade Alerts Want to know when executives and insiders are buying or selling Silence Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLN Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Silence Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Artal Group S.A.2,779,619$60.04M1.5%-7.3%9.287% 5/16/2024 Janus Henderson Group PLC625,864$13.58M0.0%N/A2.091% 5/16/2024 Redmile Group LLC2,027,669$43.80M1.6%N/A6.775% 5/15/2024 Lazard Asset Management LLC1,415$29K0.0%-37.7%0.005% 5/15/2024 M28 Capital Management LP299,400$6.47M4.8%-17.7%1.000% 5/7/2024 SG Americas Securities LLC7,000$151K0.0%+10.5%0.023% Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/22/2024 Vivo Capital LLC1,105,454$23.88M1.9%+116.7%3.694% 2/15/2024 Parkman Healthcare Partners LLC232,942$4.05M0.6%+20.8%0.778% 2/15/2024 Cantor Fitzgerald L. P.146,777$2.55M0.5%-12.7%0.490% 2/7/2024 Vivo Capital LLC510,204$8.86M0.7%N/A1.705% 1/12/2024 SG Americas Securities LLC6,333$110K0.0%N/A0.021% 11/14/2023 Lynx1 Capital Management LP235,787$2.32M1.5%N/A0.788% 8/15/2023 Cantor Fitzgerald L. P.293,893$1.62M0.0%+1.6%0.982% 8/14/2023 Lombard Odier Asset Management Europe Ltd3,415,360$18.78M0.9%+3.7%11.411% 8/14/2023 Lombard Odier Asset Management USA Corp4,120,416$18.67M0.4%+4.1%13.767% 8/11/2023 M28 Capital Management LP363,800$2.00M2.6%+149.3%1.216% 8/11/2023 Artal Group S.A.1,700,000$9.35M0.3%+236.6%5.680% 2/14/2023 Lombard Odier Asset Management Europe Ltd3,218,200$49.08M2.0%0.0%8.967% 2/10/2023 M28 Capital Management LP145,900$2.23M2.1%N/A0.407% 2/2/2023 SG Americas Securities LLC87,987$1.34M0.0%-11.1%0.245% 11/15/2022 TCG Crossover Management LLC2,104,875$21.12M6.3%N/A5.865% 11/15/2022 Parkman Healthcare Partners LLC127,458$1.28M0.4%+385.6%0.355% 11/15/2022 BVF Inc. IL1,508,416$14.89M0.6%+126.3%4.203% 11/15/2022 Cantor Fitzgerald L. P.209,886$2.11M0.0%-0.7%0.585% 11/14/2022 Point72 Asset Management L.P.550,875$5.53M0.0%+120.4%1.535% 11/14/2022UBS Oconnor LLC79,636$786K0.0%+176.4%0.222% 10/31/2022 SG Americas Securities LLC98,953$977K0.0%-2.5%0.276% 5/23/2022 Cantor Fitzgerald L. P.173,725$3.30M0.2%-31.7%0.580% 5/16/2022 Lombard Odier Asset Management Europe Ltd1,561,551$29.67M1.1%N/A5.218% 5/16/2022 Frazier Life Sciences Management L.P.881,173$16.74M1.4%N/A2.944% 2/18/2022 Lombard Odier Asset Management USA Corp3,472,521$82.96M3.2%+480.6%11.603% 2/15/2022Consonance Capital Management LP758,253$18.12M11.8%+324.1%2.534% 2/15/2022 Adage Capital Partners GP L.L.C.550,000$13.14M0.0%+23.8%1.838% 2/14/2022 Lombard Odier Asset Management USA Corp2,134,750$40.95M1.6%+256.9%7.133% 2/14/2022 Point72 Asset Management L.P.250,000$5.97M0.0%N/A0.835% 2/14/2022 Deep Track Capital LP950,798$22.72M1.6%N/A3.177% 2/14/2022 Blair William & Co. IL56,026$1.34M0.0%+26.1%0.187% 2/10/2022 Citigroup Inc.58,333$1.37M0.0%N/A0.195% 2/10/2022 Bellevue Group AG46,666$1.09M0.0%N/A0.156% 2/8/2022Frazier Management LLC886,173$21.17M1.6%N/A2.961% Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast.2/7/2022 SG Americas Securities LLC101,845$2.38M0.0%+701.8%0.340% 11/15/2021 Lombard Odier Asset Management USA Corp598,141$10.65M0.5%-34.5%1.999% 11/1/2021 SG Americas Securities LLC12,702$275K0.0%+135.1%0.042% 8/13/2021 Lombard Odier Asset Management USA Corp913,134$21.61M0.9%-23.8%3.054% 5/18/2021 BVF Inc. IL666,666$15.82M0.6%N/A2.238% 5/18/2021 Lombard Odier Asset Management USA Corp1,198,141$24.43M0.9%+121.9%4.021% 5/13/2021 SG Americas Securities LLC5,445$129K0.0%N/A0.020% 11/16/2020 Lombard Odier Asset Management USA Corp540,000$8.10M0.5%N/A1.956% (Data available from 1/1/2016 forward) SLN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLN shares? During the previous two years, 16 institutional investors and hedge funds held shares of Silence Therapeutics. The most heavily invested institutionals were Artal Group S.A. ($60.04M), Redmile Group LLC ($43.80M), Vivo Capital LLC ($23.88M), TCG Crossover Management LLC ($21.12M), Lombard Odier Asset Management Europe Ltd ($18.78M), Lombard Odier Asset Management USA Corp ($18.67M), and BVF Inc. IL ($14.89M).Learn more on SLN's institutional investors. What percentage of Silence Therapeutics stock is owned by institutional investors? 98.73% of Silence Therapeutics stock is owned by institutional investors. Learn more on SLN's institutional investor holdings. Which institutional investors have been buying Silence Therapeutics stock? Of the 15 institutional investors that purchased Silence Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TCG Crossover Management LLC ($2.10M), Redmile Group LLC ($2.03M), Artal Group S.A. ($1.19M), Vivo Capital LLC ($1.11M), BVF Inc. IL ($841.75K), Janus Henderson Group PLC ($625.86K), and M28 Capital Management LP ($363.80K). How much institutional buying is happening at Silence Therapeutics? Institutional investors have bought a total of 9,288,096 shares in the last 24 months. This purchase volume represents approximately $127.85M in transactions. Which Silence Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Silence Therapeutics stock in the last 24 months: Artal Group S.A. ($220.38K), Cantor Fitzgerald L. P. ($103.78K), M28 Capital Management LP ($64.40K), SG Americas Securities LLC ($13.47K), Lombard Odier Asset Management Europe Ltd ($1.20K), and Lazard Asset Management LLC ($855.00). How much institutional selling is happening at Silence Therapeutics? Institutional investors have sold a total of 404,086 shares in the last 24 months. This volume of shares sold represents approximately $8.30M in transactions. Related Companies: SVRA Major Shareholders ZYME Major Shareholders AVBP Major Shareholders LYEL Major Shareholders MLYS Major Shareholders PHAR Major Shareholders ORIC Major Shareholders PHAT Major Shareholders STOK Major Shareholders CALT Major Shareholders This page (NASDAQ:SLN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
